Site Search
ARCHIVED: NOT AVAILABLE FOR CREDIT
A View of Brain Injury through the Eyes of the Clinical Pathology Laboratory
The first part of the presentation focuses on the clinical workflow for traumatic brain injury (TBI) assessment as well as the presentation of several cases of sports related concussion. The second part of the talk includes a general overview of brain injury, including statistics, causes and pathophyisology of TBI-related injury. Lastly, performance of currently available TBI biomarkers and a brief discussion of novel areas of biomarker discovery is presented.
Originally presented on February 15, 2013, in Salt Lake City, Utah.
Lecture Presenters
 | Frederick Strathmann, PhD, DABCC (CC,TC) Medical Director, Toxicology Laboratory |
Dr. Strathmann is a medical director of the Toxicology Laboratory, as well as an assistant professor of pathology at the University of Utah School of Medicine. Dr. Strathmann received his PhD in pathology and laboratory medicine at the University of Rochester in New York, completed a clinical chemistry fellowship at the University of Washington in Seattle, and is ABCC board certified in clinical chemistry and toxicological chemistry.
 | David J. Petron, MD Director, Primary Care Sports Medicine |
Dr. David Petron, Assistant Professor (clinical) is a primary care orthopaedic/sports medicine specialist. He originally trained in family practice and then completed a fellowship in primary care orthopaedics and sports medicine at Michigan State University. Dr. Petron is the Director of Primary Care Sports Medicine and the team physician for the University of Utah athletic teams. He is also a team physician for the U.S. Ski Team and is the Medical Director for the Park City Ski Injury Clinic. David Petron, M.D. specializes in non-operative treatment of the spine, shoulder, knee, ankle, and foot problems. He also has a special interest in overuse injuries that lead to tendonitis. He utilizes the latest treatments for this, including shock wave therapy (Sonarex), for chronic tendon problems. Dr. Petron also has a special interest in all nonoperative treatments for osteoarthritis and performs various injections (such as Synvisc) to alleviate joint pain.
Objectives
After this presentation, participants will be able to:
- Describe the clinical workflow for TBI assessment.
- State the underlying primary and secondary pathology in TBI.
- Discuss the benefits and limitations of existing TBI biomarkers.
Sponsored by:
University of Utah School of Medicine, and ARUP Laboratories